A Research Study to Look at How Faster Aspart Works in Chinese People With Type 1 Diabetes or Type 2 Diabetes
Status:
Recruiting
Trial end date:
2022-05-24
Target enrollment:
Participant gender:
Summary
This study looks at how faster aspart reaches and stays in the blood after injection in
Chinese people with type 1 diabetes or type 2 diabetes, compared to the reference product
called NovoRapid®. Participants will get both faster aspart and NovoRapid®. The order in
which Participants get them is decided by chance. Participants will get each study medicine
once during the study meaning that they will get a total of 2 injections with study
medicines. The medicine will be injected under the skin of the lower abdomen. The study will
last for about 19-72 days. Participants will have 5 clinic visits with the study doctor
(including the one in which participants give their consent). Participants will need to stay
overnight for 2 of the 5 clinic visits. Participants will have blood samples taken during
some of the clinic visits. During the visits where participants get the study medicines,
samples of their blood will be taken several times for up to 12 hours after getting the study
medicine.